DOCTEUR

Code: 850311C-25MG D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

DOCP is suitable for use in the preparation of large unilamellar vesicles (LUVs) and in the preparation of liposomes.

General description

 En savoir plus

Votre prix
$238.28 25MG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

DOCP is suitable for use in the preparation of large unilamellar vesicles (LUVs) and in the preparation of liposomes.

General description

Inverse-phosphocholine lipids, a remix of a common phospholipid, contain headgroups with an inverted charge orientation relative to phosphocholine (PC) lipids. The iPC lipid headgroup has a quaternary amine adjacent to the bilayer interface and a phosphate that extends into the aqueous phase. Therefore iPC lipids afford a unique opportunity to investigate the biophysical and bioactivity-related ramifications of a charge inversion at the bilayer surface.

DOCP is a zwitterionic /negatively charged lipid. It possess an inverse headgroup This synthetic molecule has stronger affinity than 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS).

Packaging

5 mL Clear Glass Sealed Ampule (850311C-25mg)

5 mL Clear Glass Sealed Ampule (850311C-200mg)

assay>99% (TLC)
concentration10 mg/mL (850311C-25mg), 25 mg/mL (850311C-200mg)
formliquid
manufacturer/tradenameAvanti Polar Lipids 850311C
packagingpkg of 2 × 4 mL (850311C-200mg), pkg of 1 × 2.5 mL (850311C-25mg)
shipped indry ice
storage temp.−20°C
Cas Number1360461-57-9
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.